MMP14, matrix metallopeptidase 14, 4323

N. diseases: 340; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 AlteredExpression disease BEFREE MT1-MMP expressed by VSMCs plays a key role in limiting the progression of atherosclerosis in APOE-null mice by regulating proliferative responses and inhibiting the deterioration of VSMC function in atherogenic vascular walls. 28735290 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 Biomarker disease BEFREE These results suggested that MT1-MMP was involved in vascular inflammation and might be a good target for treating atherosclerosis. 25490770 2014
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 GeneticVariation disease BEFREE The traditional atherosclerosis risk factors were recorded, and the MMP 14 polymorphism were genotyped by Applied Biosystems 7300 Real-Time PCR System using the TaqMan assay. 24472034 2014
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 Biomarker disease LHGDN Considering the important role of apoE for lipid metabolism and atherosclerosis protection, our findings suggest that MMP-14 plays an essential role for the development of hyperlipidemia and atherosclerosis as a result of degradation of apoE. 18655030 2008